Stock Screener App

Free -

12.05

1.63% -0.20

Skye Bioscience Inc (SKYE)

Overview News Price History Discussions Forecast

Skye Bioscience Inc stock is currently priced at $12.05, with a 24-hour trading volume of 26,081. It has seen a -1.63% decreased in the last 24 hours and a -30.59% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $12.61 pivot point. If it approaches the $11.79 support level, significant changes may occur.

Previous Close:

$12.25

Open:

$12.05

24h Volume:

26,081

Market Cap:

$338.22M

Revenue:

-

Net Income/Loss:

$-37.64M

P/E Ratio:

-

EPS:

-

Net Cash Flow:

$-13.96M

1W Performance:

+6.45%

1M Performance:

-30.59%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$12.00

$12.53

52W Range:

$10.85

$17.65

Skye Bioscience Inc Stock (SKYE) Company Profile

Name

Skye Bioscience Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

-

Address

-

Employee

0

Twitter

Next Earnings Date

2024-06-05

Latest SEC Filings

SKYE's Discussions on Twitter

Skye Bioscience Inc Stock (SKYE) Latest News

(SKYE) Investment Analysis - Stock Traders Daily

Stock Traders Daily

Private equity firms are Skye Bioscience, Inc.'s (NASDAQ:SKYE) biggest owners and were hit after market cap dropped US$48m - Simply Wall St

Skye Bioscience, Inc.'s (NASDAQ:SKYE) last week's 13% decline must have disappointed private equity firms who ... - Yahoo Finance

Skye Bioscience Inc expected to post a loss of 16 cents a share - Earnings Preview - XM

Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid ... - GlobeNewswire

Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

GlobeNewswire Inc.

Skye Bioscience Inc Stock (SKYE) Financials Data

Skye Bioscience Inc (SKYE) Net Income 2024

SKYE net income (TTM) was -$37.64 million for the quarter ending December 31, 2023, a -93.23% decrease year-over-year.

Skye Bioscience Inc (SKYE) Cash Flow 2024

SKYE recorded a free cash flow (TTM) of -$13.96 million for the quarter ending December 31, 2023, a -9.34% decrease year-over-year.

Skye Bioscience Inc (SKYE) Earnings per Share 2024

SKYE earnings per share (TTM) was -$6.8286 for the quarter ending December 31, 2023, a +35.09% growth year-over-year.

$77.56

0.77%

$149.40

1.20%

$29.98

1.11%

$172.85

1.06%

$365.81

2.87%

$90.61

2.55%

Open in Yahoo | Open in Google | Open in Finviz